These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1473605)

  • 21. Oligomeric structure of A1 arginase from rat liver and A4 from kidney. Difference in charge of subunits.
    Barańczyk-Kuźma A; Porembska Z; Mochnacka I
    Acta Biochim Pol; 1976; 23(2-3):151-63. PubMed ID: 823742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and kinetic properties of Mus booduga (Gray) hepatic arginase.
    Prasad GV; Lokanatha V; Sreekanth K; Rajendra W
    J Enzyme Inhib; 1997 Dec; 12(4):255-72. PubMed ID: 9502047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and properties of rat small intestinal arginase.
    Fujimoto M; Kameji T; Kanaya A; Hagihira H
    J Biochem; 1976 Feb; 79(2):441-9. PubMed ID: 818079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hybrid, immobilised dimers of human liver arginase.
    Carvajal N; Rodríguez JP; Fernández M
    Biochim Biophys Acta; 1982 Mar; 701(3):405-7. PubMed ID: 7066335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of rat liver and kidney arginase by cadmium ion.
    Tormanen CD
    J Enzyme Inhib Med Chem; 2006 Feb; 21(1):119-23. PubMed ID: 16570515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of a unique binuclear manganese cluster in arginase.
    Kanyo ZF; Scolnick LR; Ash DE; Christianson DW
    Nature; 1996 Oct; 383(6600):554-7. PubMed ID: 8849731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physico-chemical properties of guinea pig liver arginase (author's transl)].
    Soler G; Mataix FJ; Ruiz-Amil M
    Rev Esp Fisiol; 1981 Mar; 37(1):37-44. PubMed ID: 7244325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of arginase immobilized in a fibrin clot.
    Diez A; Campo ML; Soler G
    Biotechnol Appl Biochem; 1990 Jun; 12(3):237-44. PubMed ID: 2360989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of pH and activation on the arginase activity of rat liver treated with thioacetamide].
    Feijóo B; Aylagas H; Cascales M; Santos-Ruiz A
    Rev Esp Fisiol; 1982; 38 Suppl():123-7. PubMed ID: 7146566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The purification and characterization of arginase from Saccharomyces cerevisiae.
    Green SM; Eisenstein E; McPhie P; Hensley P
    J Biol Chem; 1990 Jan; 265(3):1601-7. PubMed ID: 2404017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multiple forms of rat liver arginase].
    Trapeznikova SS; Navasardiants DG; Davtian MA
    Biokhimiia; 1982 Dec; 47(12):2022-7. PubMed ID: 7159625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinetics of inhibition of Vigna catjang cotyledon and buffalo liver arginase by L-proline and branched-chain amino acids.
    Dabir S; Dabir P; Somvanshi B
    J Enzyme Inhib Med Chem; 2006 Dec; 21(6):727-31. PubMed ID: 17252946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and properties of arginase of rat kidney.
    Kaysen GA; Strecker HJ
    Biochem J; 1973 Aug; 133(4):779-88. PubMed ID: 4748833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-chelating inhibition of the H101N variant of human liver arginase by EDTA.
    Carvajal N; Orellana MS; Bórquez J; Uribe E; López V; Salas M
    J Inorg Biochem; 2004 Aug; 98(8):1465-9. PubMed ID: 15271525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on L-arginase of the small intestine. I. Topographical distribution and some properties of the small intestine L-arginase in the rat.
    Konarska L; Tomaszewski L
    Biochem Med; 1975 Nov; 14(3):250-62. PubMed ID: 5075
    [No Abstract]   [Full Text] [Related]  

  • 36. Circular dichroic properties of rat liver arginase.
    Muszyńska G; Ber E
    Int J Biochem; 1978; 9(10):757-9. PubMed ID: 710682
    [No Abstract]   [Full Text] [Related]  

  • 37. Purification, modification, physico-chemical and pharmacokinetic characterization of arginase, an enzyme of potential use in therapy.
    Visco C; Benassi CA; Veronese FM; Miglioli PA
    Farmaco Sci; 1987 Aug; 42(8):549-59. PubMed ID: 3117587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible involvement of manganese in the catalytic mechanism of bovine liver arginase.
    Türkoğlu S; Ozer I
    Int J Biochem; 1992 Jun; 24(6):937-9. PubMed ID: 1612183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple molecular forms of mouse liver arginase.
    Spolarics Z; Bond JS
    Arch Biochem Biophys; 1988 Jan; 260(1):469-79. PubMed ID: 3277533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effect of nitrite, a stable product of nitric oxide (NO) formation, on arginase.
    Hrabák A; Bajor T; Temesi A; Mészáros G
    FEBS Lett; 1996 Jul; 390(2):203-6. PubMed ID: 8706860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.